# A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up

> **NCT04432909** · — · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Urothelial Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** The level of CNV

## Key facts

- **NCT ID:** NCT04432909
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-17
- **Primary completion:** 2022-01-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04432909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04432909, "A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04432909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*